101. Development of complement factor H based immunotherapeutic molecules against multidrug-resistant Neisseria gonorrhoeae. (October 2018) Authors: Shaughnessy, Jutamas; Lewis, Lisa A.; Zheng, Bo; DeOliveira, Rosane B.; Carr, Caleb; Bass, Isaac; Gose, Severin; Tran, Y.; Reed, George W.; Wycoff, Keith; Gulati, Sunita; Rice, Peter A.; Ram, Sanjay Journal: Molecular immunology Issue: Volume 102(2018:Oct.) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
102. Developments in anti-complement therapy; from disease to clinical trial. (October 2018) Authors: Harris, Claire L.; Pouw, Richard B.; Kavanagh, David; Sun, Ruyue; Ricklin, Daniel Journal: Molecular immunology Issue: Volume 102(2018:Oct.) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
103. Direct modulation of neural stem cell by complement C1q. (October 2018) Authors: Benavente, Francisca; Piltti, Katja; Creasman, David; Anderson, Aileen Journal: Molecular immunology Issue: Volume 102(2018:Oct.) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
104. Discordant CH50 and sC5b-9 in pharmacodynamic monitoring of eculizumab-treated patients with atypical hemolytic uremic syndrome. (October 2018) Authors: Dixon, Bradley; Frazer-Abel, Ashley Journal: Molecular immunology Issue: Volume 102(2018:Oct.) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
105. Dissection of complement pathways involved in CHPV neutralization and evasion strategy adopted by the virus to override complement. (October 2018) Authors: Johnson, John; Kunnakkadan, Umerali Journal: Molecular immunology Issue: Volume 102(2018:Oct.) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
106. Ecotin, a serine proteinase inhibitor from E. coli, is a potent complement inhibitor. (October 2018) Authors: Szakács, Dávid; Nagy, Zoltán; Héja, Dávid; Harmat, Veronika; Oroszlán, Gábor; Dobó, József; Gál, Péter; Pál, Gábor Journal: Molecular immunology Issue: Volume 102(2018:Oct.) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
107. Eculizumab can bind to protein complexes containing C5b. (October 2018) Authors: Johnson, Krista; Tamburini, Paul Journal: Molecular immunology Issue: Volume 102(2018:Oct.) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
108. Eculizumab therapy monitoring: Residual hemolysis in alternative pathway test is not caused by C5 activity. (October 2018) Authors: van den Heuvel, Lambertus; Sarlea, Andrei; Duineveld, Caroline; Mollnes, Tom Eirik; Wijnsma, Kioa; Wetzels, Jack; van de Kar, Nicole; Volokhina, Elena Journal: Molecular immunology Issue: Volume 102(2018:Oct.) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
109. Editorial Board. (October 2018) Journal: Molecular immunology Issue: Volume 102(2018:Oct.) Page Start: ii Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
110. Editorial Board. (October 2018) Journal: Progress in aerospace sciences Issue: Volume 102(2018:Oct.) Page Start: ii Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗